Curcumin Ameliorates Ovalbumin-Induced Atopic Dermatitis and Blocks the Progression of Atopic March in Mice

Abstract

Curcumin, extracted from the roots of Curcuma longa, has been used as an anti-inflammatory agent since the time of Ayurveda. The present work was designed to evaluate the potential of curcumin in amelioration of ovalbumin (OVA) induced AD in mice. Female BALB/c mice were subjected to skin OVA-patch application for a period of 1 week followed by resting period of 2 weeks, and the same protocol was repeated thrice. Curcumin was administered daily at dose of 20 mg/kg (i.p.) for 7 consecutive days during last sensitization phase. The phytochemical ameliorated the OVA-induced skin pathology as evident by normalization of epidermal thickness and suppressed infiltration of inflammatory cells in dermal region. The expression of Th2 promoting cytokines (TSLP/IL-33) and Th2 cytokines (IL-4/IL-5/IL-13/IL-31) was suppressed markedly along with reduced STAT-6 phosphorylation and GATA-3 expression. Curcumin administration also restored the redox balance and phosphorylation status of P65-NF-κB. Additionally, the epicutaneously sensitized mice challenged with aerosolized OVA developed asthmatic features which were effectively thwarted back upon curcumin treatment as reflected by data on total/differential cells in BALF and mRNA expression of Th2 cytokines in lungs. Overall, our findings demonstrate that curcumin treatment blunts the development of AD as well as associated atopic march in experimental mice.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

References

  1. 1.

    Leung, D.Y. 1995. Atopic dermatitis: the skin as a window into the pathogenesis of chronic allergic diseases. The Journal of Allergy and Clinical Immunology 96: 302–318.

    CAS  PubMed  Google Scholar 

  2. 2.

    Zheng, T., J. Yu, M.H. Oh, and Z. Zhu. 2011. The atopic march: progression from atopic dermatitis to allergic rhinitis and asthma. Allergy, Asthma & Immunology Research 3: 67–73.

    Google Scholar 

  3. 3.

    Brunner, P.M., E. Guttman-Yassky, and D.Y. Leung. 2017. The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. The Journal of Allergy and Clinical Immunology 139: S65–s76.

    CAS  PubMed  PubMed Central  Google Scholar 

  4. 4.

    Salazar-Espinosa, J.F. 2014. The atopic march. A literature review. International Journal of Medical Students 2: 119–123.

    Google Scholar 

  5. 5.

    Leung, D.Y., and T. Bieber. 2003. Atopic dermatitis. Lancet 361: 151–160.

    PubMed  Google Scholar 

  6. 6.

    Allakhverdi, Z., D.E. Smith, M.R. Comeau, and G. Delespesse. 2007. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells. Journal of Immunology 179: 2051–2054.

    CAS  Google Scholar 

  7. 7.

    Wilson, S.R., The L, L.M. Batia, K. Beattie, G.E. Katibah, S.P. McClain, et al. 2013. The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell 155: 285–295.

    CAS  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Jin, H., R. He, M. Oyoshi, and R.S. Geha. 2009. Animal models of atopic dermatitis. The Journal of Investigative Dermatology 129: 31–40.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Peng, W., and N. Novak. 2015. Pathogenesis of atopic dermatitis. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 45: 566–574.

    CAS  Google Scholar 

  10. 10.

    Furue, M., T. Chiba, G. Tsuji, D. Ulzii, M. Kido-Nakahara, T. Nakahara, and T. Kadono. 2017. Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies. Allergology International 66: 398–403.

    CAS  PubMed  Google Scholar 

  11. 11.

    Spergel, J.M., and A.S. Paller. 2003. Atopic dermatitis and the atopic march. The Journal of Allergy and Clinical Immunology 112: S118–S127.

    PubMed  Google Scholar 

  12. 12.

    Tran, M.M., D.L. Lefebvre, C. Dharma, D. Dai, W.Y.W. Lou, P. Subbarao, et al. 2017. Predicting the atopic march: results from the Canadian Healthy Infant Longitudinal Development Study. The Journal of Allergy and Clinical Immunology 141: 601–607 e8.

    PubMed  Google Scholar 

  13. 13.

    Hill, D.A., and J.M. Spergel. 2018. The atopic march: critical evidence and clinical relevance. Annals of Allergy, Asthma & Immunology 120: 131–137.

    Google Scholar 

  14. 14.

    Spergel, J.M., E. Mizoguchi, J.P. Brewer, T.R. Martin, A.K. Bhan, and R.S. Geha. 1998. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. The Journal of Clinical Investigation 101: 1614–1622.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. 15.

    Silverberg, J.I., D.B. Nelson, and G. Yosipovitch. 2016. Addressing treatment challenges in atopic dermatitis with novel topical therapies. The Journal of Dermatological Treatment 27: 568–576.

    CAS  PubMed  Google Scholar 

  16. 16.

    Nygaard, U., M. Deleuran, and C. Vestergaard. 2017. Emerging Treatment Options in Atopic Dermatitis: Topical Therapies. Dermatology 233: 333–343.

    PubMed  Google Scholar 

  17. 17.

    Huang, A., C. Cho, D.Y.M. Leung, and K. Brar. 2018. Atopic dermatitis: early treatment in children. Current Treatment Options in Allergy 4: 355–369.

    Google Scholar 

  18. 18.

    Thakare, V.N., M.M. Osama, and S.R. Naik. 2013. Therapeutic potential of curcumin in experimentally induced allergic rhinitis in guinea pigs. International Immunopharmacology 17: 18–25.

    CAS  PubMed  Google Scholar 

  19. 19.

    Ammon, H.P., and M.A. Wahl. 1991. Pharmacology of Curcuma longa. Planta Medica 57: 1–7.

    CAS  PubMed  Google Scholar 

  20. 20.

    Karaman, M., F. Firinci, S. Cilaker, P. Uysal, K. Tugyan, O. Yilmaz, N. Uzuner, and O. Karaman. 2012. Anti-inflammatory effects of curcumin in a murine model of chronic asthma. Allergologia et Immunopathologia 40: 210–214.

    CAS  PubMed  Google Scholar 

  21. 21.

    Oh, S.W., J.Y. Cha, J.E. Jung, B.C. Chang, H.J. Kwon, B.R. Lee, et al. 2011. Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-kappaB inhibition. Journal of Ethnopharmacology 136: 414–421.

    CAS  PubMed  Google Scholar 

  22. 22.

    Sakai, H., K. Sato, F. Sato, Y. Kai, K. Mandokoro, K. Matsumoto, S. Kato, T. Yumoto, M. Narita, and Y. Chiba. 2017. Curcumin inhibits epigen and amphiregulin upregulated by 2,4,6-trinitrochlorobenzene associated with attenuation of skin swelling. Inflammation Research 66: 663–678.

    CAS  PubMed  Google Scholar 

  23. 23.

    Moon, P.D., H.J. Jeong, and H.M. Kim. 2013. Down-regulation of thymic stromal lymphopoietin by curcumin. Pharmacological Reports 65: 525–531.

    CAS  PubMed  Google Scholar 

  24. 24.

    Sethi, G.S., and A.S. Naura. 2018. Progressive increase in allergen concentration abrogates immune tolerance in ovalbumin-induced murine model of chronic asthma. International Immunopharmacology 60: 121–131.

    CAS  PubMed  Google Scholar 

  25. 25.

    Sahu, B., R. Sandhir, and A.S. Naura. 2018. Two hit induced acute lung injury impairs cognitive function in mice: a potential model to study cross talk between lung and brain. Brain, Behavior, and Immunity 73: 633–642.

    CAS  PubMed  Google Scholar 

  26. 26.

    Dharwal, V., and A.S. Naura. 2018. PARP-1 inhibition ameliorates elastase induced lung inflammation and emphysema in mice. Biochemical Pharmacology 150: 24–34.

    CAS  PubMed  Google Scholar 

  27. 27.

    Lowry, O.H., N.J. Rosebrough, A.L. Farr, and R.J. Randall. 1951. Protein measurement with the Folin phenol reagent. The Journal of Biological Chemistry 193: 265–275.

    CAS  PubMed  Google Scholar 

  28. 28.

    Wang, H., and J.A. Joseph. 1999. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radical Biology & Medicine 27: 612–616.

    CAS  Google Scholar 

  29. 29.

    Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358.

    CAS  PubMed  Google Scholar 

  30. 30.

    Levine, R.L., D. Garland, C.N. Oliver, A. Amici, I. Climent, A.G. Lenz, B.W. Ahn, S. Shaltiel, and E.R. Stadtman. 1990. Determination of carbonyl content in oxidatively modified proteins. Methods in Enzymology 186: 464–478.

    CAS  PubMed  Google Scholar 

  31. 31.

    Kono, Y. 1978. Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase. Archives of Biochemistry and Biophysics 186: 189–195.

    CAS  PubMed  Google Scholar 

  32. 32.

    Luck, H. 1965. Catalase. methods of enzymatic anaylsis, 885–894. New York: Academic Press.

    Google Scholar 

  33. 33.

    Moron, M.S., J.W. Depierre, and B. Mannervik. 1979. Levels of glutathione, glutathione reductase and glutathione S-transferase activities in rat lung and liver. Biochimica et Biophysica Acta 582: 67–78.

    CAS  PubMed  Google Scholar 

  34. 34.

    Wang, G., T. Savinko, H. Wolff, M.C. Dieu-Nosjean, L. Kemeny, B. Homey, A.I. Lauerma, and H. Alenius. 2007. Repeated epicutaneous exposures to ovalbumin progressively induce atopic dermatitis-like skin lesions in mice. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 37: 151–161.

    CAS  Google Scholar 

  35. 35.

    Wang, Y.H., and Y.J. Liu. 2009. Thymic stromal lymphopoietin, OX40-ligand, and interleukin-25 in allergic responses. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 39: 798–806.

    CAS  Google Scholar 

  36. 36.

    Nygaard, U., M. Hvid, C. Johansen, M. Buchner, R. Folster-Holst, M. Deleuran, et al. 2016. TSLP, IL-31, IL-33 and sST2 are new biomarkers in endophenotypic profiling of adult and childhood atopic dermatitis. Journal of the European Academy of Dermatology and Venereology 30: 1930–1938.

    CAS  PubMed  Google Scholar 

  37. 37.

    Ji, H., and X.K. Li. 2016. Oxidative Stress in Atopic Dermatitis. Oxidative Medicine and Cellular Longevity 2016: 2721469.

    PubMed  PubMed Central  Google Scholar 

  38. 38.

    Shakeri, F., M. Soukhtanloo, and M.H. Boskabady. 2017. The effect of hydro-ethanolic extract of Curcuma longa rhizome and curcumin on total and differential WBC and serum oxidant, antioxidant biomarkers in rat model of asthma. Iranian Journal of Basic Medical Sciences 20: 155–165.

    PubMed  PubMed Central  Google Scholar 

  39. 39.

    Leung, D.Y. 1999. Pathogenesis of atopic dermatitis. The Journal of Allergy and Clinical Immunology 104: S99–S108.

    CAS  PubMed  Google Scholar 

  40. 40.

    Bantz, S.K., Z. Zhu, and T. Zheng. 2014. The Atopic March: Progression from Atopic Dermatitis to Allergic Rhinitis and Asthma. J Clin Cell Immunol 5: 202.

    PubMed  PubMed Central  Google Scholar 

  41. 41.

    Lowe, A.J., D.Y.M. Leung, M.L.K. Tang, J.C. Su, and K.J. Allen. 2018. The skin as a target for prevention of the atopic march. Annals of Allergy, Asthma & Immunology 120: 145–151.

    Google Scholar 

  42. 42.

    Shakeri, A., A.F.G. Cicero, Y. Panahi, M. Mohajeri, and A. Sahebkar. 2019. Curcumin: A naturally occurring autophagy modulator. Journal of Cellular Physiology 234: 5643–5654.

    CAS  PubMed  Google Scholar 

  43. 43.

    Zheng, T., and Z. Zhu. 2005. Lessons from murine models of atopic dermatitis. Current Allergy and Asthma Reports 5: 291–297.

    CAS  PubMed  Google Scholar 

  44. 44.

    Saluja, R., A. Zoltowska, M.E. Ketelaar, and G. Nilsson. 2016. IL-33 and Thymic Stromal Lymphopoietin in mast cell functions. European Journal of Pharmacology 778: 68–76.

    CAS  PubMed  Google Scholar 

  45. 45.

    Soumelis, V., P.A. Reche, H. Kanzler, W. Yuan, G. Edward, B. Homey, M. Gilliet, S. Ho, S. Antonenko, A. Lauerma, K. Smith, D. Gorman, S. Zurawski, J. Abrams, S. Menon, T. McClanahan, R. de Waal-Malefyt Rd, F. Bazan, R.A. Kastelein, and Y.J. Liu. 2002. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nature Immunology 3: 673–680.

    CAS  PubMed  Google Scholar 

  46. 46.

    Chen, B.L., Y.Q. Chen, B.H. Ma, S.F. Yu, L.Y. Li, Q.X. Zeng, Y.T. Zhou, Y.F. Wu, W.L. Liu, J.B. Wan, Y. Yang, and C.W. Li. 2018. Tetrahydrocurcumin, a major metabolite of curcumin, ameliorates allergic airway inflammation by attenuating Th2 response and suppressing the IL-4Ralpha-Jak1-STAT6 and Jagged1/Jagged2 -Notch1/Notch2 pathways in asthmatic mice. Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology 48: 1494–1508.

    CAS  Google Scholar 

  47. 47.

    Chong, L., W. Zhang, Y. Nie, G. Yu, L. Liu, L. Lin, S. Wen, L. Zhu, and C. Li. 2014. Protective effect of curcumin on acute airway inflammation of allergic asthma in mice through Notch1-GATA3 signaling pathway. Inflammation 37: 1476–1485.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. 48.

    Brown, H.A., and J.M. Hanifin. 1990. Atopic dermatitis. Current Opinion in Immunology 2: 531–534.

    CAS  Google Scholar 

  49. 49.

    Brandt, E.B., and U. Sivaprasad. 2011. Th2 Cytokines and Atopic Dermatitis. Journal of Clinical & Cellular Immunology 2: 110.

    Google Scholar 

  50. 50.

    Yoshihisa, Y., T. Andoh, K. Matsunaga, M.U. Rehman, T. Maoka, and T. Shimizu. 2016. Efficacy of Astaxanthin for the Treatment of Atopic Dermatitis in a Murine Model. PLoS One 11: e0152288.

    PubMed  PubMed Central  Google Scholar 

  51. 51.

    Addor, F.A.S. 2017. Antioxidants in dermatology. Anais Brasileiros de Dermatologia 92: 356–362.

    PubMed  PubMed Central  Google Scholar 

  52. 52.

    Briganti, S., and M. Picardo. 2003. Antioxidant activity, lipid peroxidation and skin diseases. What's new. Journal of the European Academy of Dermatology and Venereology 17: 663–669.

    CAS  PubMed  Google Scholar 

  53. 53.

    Morgan, M.J., and Z.G. Liu. 2011. Crosstalk of reactive oxygen species and NF-kappaB signaling. Cell Research 21: 103–115.

    CAS  PubMed  Google Scholar 

  54. 54.

    Sahebkar, A., A.F.G. Cicero, L.E. Simental-Mendia, B.B. Aggarwal, and S.C. Gupta. 2016. Curcumin downregulates human tumor necrosis factor-alpha levels: A systematic review and meta-analysis ofrandomized controlled trials. Pharmacological Research 107: 234–242.

    CAS  PubMed  Google Scholar 

  55. 55.

    Buhrmann, C., A. Mobasheri, F. Busch, C. Aldinger, R. Stahlmann, A. Montaseri, and M. Shakibaei. 2011. Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway. The Journal of Biological Chemistry 286: 28556–28566.

    CAS  PubMed  PubMed Central  Google Scholar 

  56. 56.

    Mollazadeh, H., A.F.G. Cicero, C.N. Blesso, M. Pirro, M. Majeed, and A. Sahebkar. 2019. Immune modulation by curcumin: The role of interleukin-10. Critical Reviews in Food Science and Nutrition 59: 89–101.

    CAS  PubMed  Google Scholar 

  57. 57.

    Han, H., W. Xu, M.B. Headley, H.K. Jessup, K.S. Lee, M. Omori, M.R. Comeau, A. Marshak-Rothstein, and S.F. Ziegler. 2012. Thymic stromal lymphopoietin (TSLP)-mediated dermal inflammation aggravates experimental asthma. Mucosal Immunology 5: 342–351.

    CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

This research work was supported by grants from Department of Biotechnology, Government of India [BT/PR17968/MED/122/33/2016 and BT/RLF/Re-entry/36/2012]; Department of Science and Technology, New Delhi, India [DST-PURSE II] and University Grants Commission, New Delhi, India [UGC-SAP] to ASN. We also acknowledge the UGC-BSR Senior Research Fellowship to SS from UGC, New Delhi, India.

Author information

Affiliations

Authors

Contributions

Conceptualization and design of experiments was done by Amarjit S Naura and Sukriti Sharma; Experiments were performed by Sukriti Sharma; Analysis of the data was done by Amarjit S Naura, Sukriti Sharma, and Gurupreet S Sethi. The draft of the manuscript was prepared by Sukriti Sharma and all authors reviewed and approved the final manuscript.

Corresponding author

Correspondence to Amarjit S. Naura.

Ethics declarations

Conflict of Interest

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic Supplementary Material

ESM 1

(PDF 268 kb)

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Sharma, S., Sethi, G.S. & Naura, A.S. Curcumin Ameliorates Ovalbumin-Induced Atopic Dermatitis and Blocks the Progression of Atopic March in Mice. Inflammation 43, 358–369 (2020). https://doi.org/10.1007/s10753-019-01126-7

Download citation

KEY WORDS

  • atopic dermatitis
  • curcumin
  • atopic march
  • asthma
  • ovalbumin